Cargando…
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma
Multiple myeloma (MM) is a hematologic malignancy strongly characterized by genomic instability, which promotes disease progression and drug resistance. Since we previously demonstrated that LIG3-dependent repair is involved in the genomic instability, drug resistance and survival of MM cells, we he...
Autores principales: | Caracciolo, Daniele, Scionti, Francesca, Juli, Giada, Altomare, Emanuela, Golino, Gaetanina, Todoerti, Katia, Grillone, Katia, Riillo, Caterina, Arbitrio, Mariamena, Iannone, Michelangelo, Morelli, Eugenio, Amodio, Nicola, Di Martino, Maria Teresa, Rossi, Marco, Neri, Antonino, Tagliaferri, Pierosandro, Tassone, Pierfrancesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776341/ https://www.ncbi.nlm.nih.gov/pubmed/32079692 http://dx.doi.org/10.3324/haematol.2019.240713 |
Ejemplares similares
-
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
por: Caracciolo, Daniele, et al.
Publicado: (2021) -
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2021) -
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
por: Scionti, Francesca, et al.
Publicado: (2022) -
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma
por: Scionti, Francesca, et al.
Publicado: (2023) -
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma
por: Stamato, Maria Angelica, et al.
Publicado: (2017)